uniQure Announces Company Participation at Citi Healthcare Conference
August 24 2017 - 7:00AM
Live webcast of gene therapy
panel discussion on Thursday, September 7 at 11:00 am EDT
LEXINGTON, Mass and AMSTERDAM, the
Netherlands, Aug. 24, 2017 (GLOBE NEWSWIRE) -- uniQure
N.V. (NASDAQ:QURE), a leading gene therapy company advancing
transformative therapies for patients with severe medical needs,
today announced that it will participate in a gene therapy panel
discussion and host investor meetings during the Citi Healthcare
Conference held in Boston from September 5-7, 2017.
Matt Kapusta, chief executive
officer of uniQure, will participate on the analyst-moderated panel
entitled, "Gene-Therapy Manufacturing and Regulatory - Challenges
and Opportunities" on Thursday, September 7, 2017 at 11:00 am
EDT. A live webcast of the panel discussion can be accessed
through the link displayed in the Investor Section of the
uniQure website at
http://uniqure.com/investors-newsroom/events-presentations.php.
A replay of the webcast will be available within 24 hours following
the event, and will remain available for at least two weeks.
About
uniQure
uniQure is delivering on the promise of gene therapy - single
treatments with potentially curative results. We are leveraging our
modular and validated technology platform to rapidly advance a
pipeline of proprietary and partnered gene therapies to treat
patients with hemophilia, Huntington's disease and cardiovascular
diseases. www.uniQure.com
uniQure Contacts:
For Investors:
Maria E. Cantor
Direct: 339-970-7536
Mobile: 617-680-9452
m.cantor@uniQure.com
Eva M. Mulder
Direct: +31 20 240 6103
Mobile: +31 6 52 33 15 79
e.mulder@uniQure.com
For Media:
Tom Malone
Direct: 339-970-7558
Mobile: 339-223-8541
t.malone@uniQure.com
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: uniQure N.V. via Globenewswire
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jun 2024 to Jul 2024
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jul 2023 to Jul 2024